Sign up Australia
Proactive Investors - Run By Investors For Investors

SDI gains approval to market Riva Star as a dental desensitiser in the US

The company has previously gained registration for the product in Latin American countries as an anti-decay agent.
Image of woman holding a sign with decayed teeth
FDA registration permits use of the product to relieve tooth sensitivity

SDI Limited (ASX:SDI) has gained Federal Drug Administration (FDA) approval to market Riva Star as a dental desensitiser in the US, the world’s largest dental market.

The FDA registration permits use of Riva Star as a new generation desensitiser that immediately relieves tooth sensitivity.

SDI previously gained Riva Star registration in several Latin American countries, including Brazil, Peru and Colombia as an anti-caries (decay) agent.

Silver diamine fluoride a key ingredient

The product's key ingredients are silver diamine fluoride (SDF), an antimicrobial solution which stops decay in teeth, and potassium iodide (KI).

A two-step global patented procedure minimises the risk of staining the tooth.

By applying the KI solution over the SDF, a precipitate is formed, which results in a tooth-coloured appearance for the patient.

Tooth decay increasing in some communities

Tooth decay is one of the most common global health problems and recent evidence suggests that the incidence of tooth decay in some communities is growing.

CEO Samantha Cheetham said: “This product is an innovative preventative solution for the company and adds to our leading position in the dental industry globally.

“At this stage, we do not expect it to generate material sales in the short term, as more clinical studies and papers need to be completed from key opinion leaders in the dentistry profession.”

View full SDI profile View Profile

SDI Ltd Timeline

Related Articles

An energy plant
August 13 2018
The exclusive contract will run its course for two years and includes a one -year extension option
Flow chart of the Hazer Process
March 21 2018
The Hazer Process could disrupt the $100 billion hydrogen production market.
Vault online software in the cloud image
August 08 2018
The company has achieved strong sales on the back of its risk and safety management software systems.

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use